|
|
Arsenal Capital Partners, founded in 2000, is an industry-focused investor in middle-market niche products and services companies. The firm has $1.67 billion of committed capital under management and targets businesses across all sectors in the $50 to $250 million enterprise value range. In April 2013, Arsenal closed its third fund, Capital Partners III, with $875 million worth of commitments. The firm works closely with its portfolio companies by aggregating buying power and sharing best practices in procurement & supply chain, human capital, information technology, quality & six sigma, and program management. The firm focuses on the following end markets: Healthcare Pharmaceutical Services (Medical Devices, Healthcare Services); Specialty Industrial Specialty Chemicals & Materials (Aerospace Defense, Transportation & Logistics, Commercial / Industrial Services, Printing & Packaging); and Financial Services (Transaction Processing, Business Services, Financial Technology, Commercial & Consumer Finance, Insurance & Brokerage, Asset Management). Arsenal Capital Partners targets equity investments of $25 to $75 million in each portfolio company. Arsenal has an additional office in Shanghai, China. The firm has 250+ platform an add-on transactions.
|
